Stockreport

Biotech Heavyweight Amgen Enters The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF Amgen stock is facing concerns that biosimilars could chip away at some of its biggest moneymakers. Is it time to buy shares of the biotech company? The post Biotech Hea [Read more]